Biocryst Pharmaceuticals Inc (BCRX)
EBITDA Margin
-32.21%
TTM · Period ending:
BCRX EBITDA Margin
Latest reported-32.21%period ending
Latest reported-32.21%period ending
BCRX TTM EBITDA Margin (-1066.67% → -32.21%)
TTM ebitda margin
High-resolution chart · PNG
BCRX ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -294.1155% | |
| 8,999.4192% | |
| -259.3277% | |
| -149.5518% | |
| -160.5622% | |
| -97.8835% | |
| -300.28% | |
| -238.1724% | |
| -21.6818% | |
| -67.1642% | |
| -78.7879% | |
| -109.6774% | |
| -3,966.6667% | |
| -706.25% | |
| -580% | |
| -412% | |
| -370.3704% | |
| -293.3333% | |
| -276.9231% | |
| -331.8182% | |
| -350% | |
| -1,875% | |
| -1,680% | |
| -1,350% | |
| -1,085.7143% | |
| -1,114.2857% | |
| -1,066.6667% |